Gennex Laboratories- Partly Paid up Equity Shares (Rights Issue): Disclosure Pursuant To Regulation 23(9) Of The SEBI (LODR) Regulations 2015 For The Half Year Ended September 30 2022

Pursuant to the provision of Regulation.23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit the attached note on Related party Transaction on Consolidated basis for the Half Year ended September 30 2022.We request you to take note of the above information on record and acknowledge the receipt of the same